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Conventional vaginal formulations are associated with disadvantages of low reten-
tion in the vaginal epithelium, leakage and messiness, thereby causing inconvenience to
the user. To circumvent these problems, bioadhesive drug delivery systems are propa-
gated (1). Bioadhesive vaginal tablet formulations capable of delivering the active agent
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The aim of the present investigation was to prepare and
evaluate novel bioadhesive vaginal tablets containing
clotrimazole loaded microspheres in order to provide
long-term therapeutic activity at the site of infection.
Tablets were prepared by incorporating drug loaded mi-
crospheres and using bioadhesive polymers hydroxy-
propylmethylcellulose, sodium carboxymethylcellulose
and Carbopol. Microspheres were prepared by the spray
drying technique using Eudragit RS-100 and Eudragit
RL-100. Microspheres were characterized by SEM, DSC,
FTIR, particle size analysis and evaluated for percentage
yield, drug loading, encapsulation efficiency and in vitro
drug release. To achieve bioadhesion to the mucosal tis-
sue, optimized microspheres were incorporated into bio-
adhesive tablets and were evaluated for in vitro drug re-
lease, in vitro and in vivo mucoadhesion. FTIR and DSC
studies showed that no chemical interaction occurred
between the drug and polymers. The sphericity factor
indicated that the prepared microspheres were spherical.
Formulation Mt6 indicated a controlled in vitro drug re-
lease and good bioadhesive strength. The in vivo images
confirmed the bioadhesion and retention property of
tablets up to 24 h. The results indicated that this drug
delivery system can be explored for controlled intrava-
ginal drug release.
Keywords: clotrimazole, microspheres, bioadhesive vagi-
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for an extended period of time at a predictable rate have been developed and studied re-
cently (2). Mucoadhesive drug delivery systems offer several advantages such as local-
ization at a given target site, prolonged residence time at the site of drug absorption, and
intensified contact with the mucosa increasing the drug concentration gradient. Hence,
uptake and consequently bioavailability of the drug may be increased, frequency of dos-
ing reduced and patient compliance improved (3). Among the various routes, the vaginal
and rectal lumen have also been explored for the delivery of active agents both systemi-
cally and locally. Active agents intended for systemic delivery by this route of adminis-
tration bypass the hepatic first-pass metabolism. Delivery systems quite often suffer
from migration within the vaginal/rectal lumen, which might affect the delivery of the
active agent to the specific location. Use of mucoadhesive polymers for the development
of delivery systems helps in reducing their migration, thereby promoting better thera-
peutic efficacy. Various mucoadhesive polymers like poly(acrylates), chitosan, cellulose
derivatives (hydroxyethylcellulose, hydroxypropylcellulose and hydroxypropylmethyl-
cellulose), hyaluronic acid derivatives, pectin, tragacanth, starch, poly(ethylene glycol),
sulfated polysaccharides, carrageenean, Na-alginate and gelatine have been used in vag-
inal drug delivery (4).
Imidazole derivative clotrimazole (CTZ) is a broad-spectrum antimycotic agent ef-
fective against pathogenic dermatophytes, yeasts and several species of Candida, Tricho-
phyton, Microsporum, Epidermophyton and Malassezia. However, clotrimazole is known to
be very effective locally and causes no major side effects.
Conventional drug delivery systems (exemplified by tablets, creams, gels, pessaries,
and foams) suffer from poor retention in the vaginal tract, since they are removed in a
short time by the tract’s self-cleansing action due to vaginal fluids (5). Multiple daily
doses of conventional formulations result in poor patient compliance. To overcome such
problems, delivery systems with bioadhesive polymers that prolong drug action on the
vaginal mucosa were developed (6–8). A thorough literature search revealed a lack of in-
formation on combinations of HPMC, SCMC and Carbopol based bioadhesive vaginal
tablets for controlled drug release containing clotrimazole loaded microspheres. Deve-
lopment of a controlled release delivery system for clotrimazole would provide long-
-term therapeutic concentrations at the site of infection by a single dose, leading to eradi-
cation of the infection (8).
The main goal of this research was to design and evaluate a vaginal delivery system
for the local treatment of vaginal Candidiasis.
EXPERIMENTAL
Materials
Clotrimazole was a gift sample from KAPL, India. Eudragits RS 100 and RL 100 were
obtained from Vikram Thermo Ltd, India. Dichloromethane, hydroxypropyl-methyl-
cellulose (HPMC) and sodium carboxymethylcellulose (SCMC) were purchased from
Loba Chemie Pvt Ltd., India. Carbopol 934 was a gift sample from Micro labs, India. All
other reagents used in the study were of analytical grade.
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Preparation of microspheres by spray drying
Weighted amounts of Eudragit RS-100 or Eudragit RL-100 (as release controlling
agents) were dissolved in dichloromethane. To this solution, a required amount of CTZ
was added. Spray drying was co-currently performed using a LSD-48 mini spray drier
(JISL, India) with a standard 0.5 mm nozzle. Inlet temperature was maintained at 80 °C,
flow rate was maintained at 5-6 mL min–1, compressed spray air flow was maintained at
10 L min–1 and air pressure was kept at 1.47 x 105 N m–2. Solvent evaporation by a flow
of heated air aspirated by a pump (29–35 ASP, corresponding to 50–60 mm of H2O nega-
tive pressure) induced the formation of solid microspheres from the drop. The obtained
microspheres were separated in a cyclone separator and settled into a collector (9). For-
mulation chart of microspheres is given in Table I. The spray drying method of micro-
encapsulation involves dispersion of a solution containing polymer and drug with an
additional medium in which the drug and polymer cannot dissolve. Additional medium
is required to precipitate the microspheres.
Micromeritic properties
Angle of repose is the maximum angle possible between the surface of a pile of mi-
crospheres and the horizontal plane. Fixed funnel method was employed (10).
Apparent bulk density was determined by pouring the samples in bulk into a grad-
uated cylinder. Tapped density was determined by placing a graduated cylinder con-
taining a known mass of powder on a mechanical tapper apparatus (ETD-1020, Electro-
lab, India). Samples were tapped until no further reduction in volume of the sample was
observed. Carr’s index was calculated (10).
Compatibility studies
Fourier transform infrared spectroscopy (FTIR). – Potassium bromide was mixed with
the sample, compressed into a pellet and spectra were taken between 400–4000 cm–1 us-
ing an FTIR spectrophotometer (FT-IR-8400-S, Shimadzu, Japan).
Differential scanning calorimetry (DSC). – About 2 mg of sample was placed in an alu-
minium pan and hermetically sealed. DSC thermograms were recorded from 0 to 200 °C.
The instrument was calibrated using high purity indium metal as standard. Dynamic
scans were taken in a nitrogen atmosphere at the heating rate of 5 °C min–1 (DSC-60 Shi-
madzu).
Particle size analysis and sphericity of microspheres
Particle size analysis of microspheres was carried out by optical microscopy. About
200 microspheres were selected randomly and their size was determined using an opti-
cal microscope (SK-6, Suswox Optic, India) fitted with a standard micrometer scale.
To determine sphericity, tracings of CTZ microspheres (magnification 45×) were
taken on black paper using a camera lucida (Model Prism type, Rolex, India). Sphericity
factor (S) was calculated as:
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where A is the area (cm2) and P is the perimeter (cm) of the circular tracing (11).
Scanning electron microscopy (SEM) photographs were taken using a scanning elec-
tron microscope (Joel-LV-5600, Japan) at room temperature. Samples were fixed on a
scanning electron microscope sample holder with a double-sided adhesive tape and coa-
ted with a layer of gold of 1.5 × 10–10 m for 2 min using a sputter coater (Edwards 3-150
Å, England) in a vacuum of 30.4 kPa of argon gas. Photographs were observed for mor-
phological characteristics and to confirm the spherical nature of microspheres.
Drug loading and encapsulation efficiency
Microspheres (100 mg) were extracted with 5 mL of methanol, diluted with pH 4.5
citrate-phosphate buffer, filtered and analyzed for drug content after suitable dilution, at
264 nm (12).
Tablet preparation
Incorporation of microspheres in a tablet was carried out in the following way. Op-
timized microspheres equivalent to 100 mg of clotrimazole along with HPMC, SCMC,
Carbopol, magnesium stearate and calcium hydrogenphosphate were physically mixed
and were punched into tablet by direct compression using a tablet punching machine
(Rimek Minipress, India) (Table II) (13). Instead of microspheres, 100 mg of pure clotri-
mazole was used to get a control tablet.
Evaluation of tablets
Hardness of core tablets was measured using an Erweka tablet hardness tester (IHT
100, Erweka, India). Ten tablets were tested for each batch. Ten tablets were randomly
selected and the average mass and standard deviation were calculated. For thickness
measurements, ten tablets were randomly selected from each batch and measured by a
micrometer screw gauge (293–821, Mitutoyo, Japan). Ten tablets were weighed and
placed in the Roche friabilator apparatus (EF-2, Electrolab, India) and rotated at 25 rpm
for 4 minutes. Afterwards, the tablets were dedusted and weighed again. Percentage fri-
ability was calculated (14).
Drug content. – Ten tablets of each formulation were crushed in a mortar. A quantity
of powder equivalent to 100 mg of CTZ was taken, transferred to a 100-mL volumetric
flask and diluted with pH 4.5 citrate phosphate buffer (15). Absorbance was measured at
264 nm.
Swelling. – Each tablet was weighed and then placed in 600 mL citrate-phosphate
buffer pH 4.5 in a basket at 37 ± 0.5 °C. The samples were periodically weighed after re-
moving the excess water on the surface with a filter paper (2).
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In vitro mucoadhesive strength. – Sheep vaginal mucosa was used as a model mem-
brane. The mucoadhesive potential of each tablet formulation was determined by mea-
suring the force required to detach the formulation from the vaginal mucosal tissue. A
section of sheep vaginal mucosa was fixed on each of the two glass slides using cyano-
acrylate adhesive. The formulation was placed on the first slide while another slide with
mucosal section attached to a pan was placed in inverted position above the first slide.
Both slides with the formulation between them were held in contact for 5 min using a
preload of 50 g to ensure intimate contact between them. Weight was then kept rising in
the pan until the mucosa on each slide got detached from each other. The weight requi-
red to detach the tablet from vaginal mucosa was noted as bioadhesive strength (16).
In vitro drug release studies
Release studies were carried out on all formulations in triplicate, employing a bas-
ket type dissolution tester-USP XXII (TDT-08L, Electrolab, India) using 600 mL of pH 4.5
citrate phosphate buffer as dissolution medium at 100 rpm at 37 ± 0.5 °C to mimic the
vaginal conditions (15). Five mL of the sample was withdrawn at different intervals and
analyzed by the UV method at 264 nm (2, 7, 17).
In vitro antifungal studies
Antifungal activity was evaluated by the cup-plate method using agar plates inocu-
lated with Candida albicans. A volume of 20 mL of sterilized agar media was dispersed
into a sterilized Petri dish and allowed to solidify. Each Petri dish was divided into two
sectors, and a bore (6 mm) was made in each sector using a sterile cork borer. Each bore
in a different sector was loaded with a placebo tablet (negative control), metronidazole
pure drug (positive control) and a microspheres loaded CTZ tablet. Petri dishes were in-
cubated at the temperature of 37 ± 0.5 °C for 24 h to allow the growth of microorgan-
isms. The zone of inhibition produced by the microspheres loaded CTZ tablet towards
the organism was measured (mm).
In vivo bioadhesive strength
Three female rabbits, weighing between 2.6–3.2 kg, were taken for the study. Ethical
clearance for the handling of experimental animals was obtained from the institutional
animal Ethical Committee (IAEC) of the JSS College of Pharmacy, Mysore, India. The ani-
mals were fasted for 12 h and optimized bioadhesive tablets were administered intra-
vaginally. Pictures were taken using a 3-mm probe (laparoscopic probe with a 3-chip
camera and Neosurge turn light source) (CXS-OP-SZL, Crystal Photonics, Germany) at
different time intervals.
Statistical data analysis
Statistical data analysis was performed using the t-test.
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RESULTS AND DISCUSSION
In the present study, microspheres were prepared using various polymers. Spray
drying method was optimized by using Eudragit RS-100, Eudragit RL-100 and a solvent
(dichloromethane) to entrap the drug. Being a water insoluble drug, CTZ could be en-
trapped into water insoluble polymers by the spray drying method.
Polymers Eudragit RL 100 and RS 100 were selected for microsphere preparation
because they are insoluble in aqueous media but are permeable, have the ability to pro-
duce pH-independent drug-release profiles and have release rate controlling ability,
non-toxicity, non-irritancy, stability at vaginal pH and compatibility with the drug (18).
HPMC, SCMC, and Carbopol 934 were selected as polymers for tablet preparation be-
cause they have provided excellent bioadhesive properties on the mucosal surface and
have been used in formulating various delivery systems (6).
The optimal inlet temperature for the preparation of CTZ microspheres was found
to be 80 °C while the optimal feed flow rate was 5–6 mL min–1. Increase in the feed flow
rate resulted in particle size reduction and a decrease in the yield of microspheres. On
the other hand, decrease in the feed flow rate below 5–6 mL min–1 increased the particle
size, which was not suitable for pharmaceutical purposes. The solvent in the droplets
could not be fully evaporated when the feed rate was > 5–6 mL min–1. It was observed
that some of liquid droplets were attached inside the wall of the main chamber. Hence,
an increase in feed rate led to higher solvent contents, especially at low inlet tempera-
tures. Higher inlet temperature promoted a decrease in residual solvent by enhancing
solvent evaporation.
It was observed that also compressed air flow and air pressure influenced the shape
as well as the size distribution of microspheres, possibly because of variable shear force
experienced by the particulate system. The average microsphere size increased with a
decrease in spray flow. At higher feed rate and pressure, the system tended to produce
irregularly shaped microspheres when it was not possible to distinguish between indi-
vidual microspheres.
The flow property of microspheres was studied by calculating the angle of repose (q
in degrees) and compressibility index (CI, %). The obtained data along with related pa-
rameters are presented in Table I. The values of q ranged from 31.5 to 35.2° indicating
that the microspheres had good flow properties. The CI value was found to be in the
range of 19.4 to 25.3 %, which also indicated good flow properties.
FTIR studies
The FTIR spectra of pure CTZ and microsphere formulation M4 are reported in Fig. 1.
Positions of peaks in FTIR spectra of pure CTZ were compared with the spectrum of
CTZ containing microspheres. Characteristic IR absorption peaks of pure CTZ of the aro-
matic C-H stretch (3167 cm–1), aromatic C=C stretch (1589 cm–1), C=N stretch (1570
cm–1) and aromatic C-H bending (761 cm–1) were present in the spectrum of the CTZ
tablet loaded with microspheres. Peaks at wavelengths corresponding to the pure drug
were also observed in the microsphere formulation M4. The FTIR spectra of the pure
drug and formulation indicated that the positions of characteristic peaks of CTZ were
not altered after their successful entrapment in the microspheres, suggesting the absence
of interactions between the drug and other components of the formulation (19).
365
N. Vishal Gupta et al.: Bioadhesive vaginal tablets containing spray dried microspheres loaded with clotrimazole for treatment of
vaginal Candidiasis, Acta Pharm. 63 (2013) 359–372
Differential scanning calorimetry (DSC)
DSC thermograms of pure drug and drug loaded microspheres (M4) are shown in
Fig. 2. The DSC thermogram of pure CTZ showed a sharp melting endotherm at 144.47 °C.
This melting endotherm was also observed for M4 at 144.23 °C, indicating the absence of
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Fig. 1. FTIR spectra of pure drug clotrimazole and microspheres M4.
Fig. 2. DSC spectra of pure clotrimazole and microspheres M4.
drug and polymer interactions. However, the melting endotherm of M4 was not as sharp
as that of pure CTZ, which may be a result of the presence of polymers and the change
in heat capacity of the polymer as it undergoes transition from the glassy to liquid state
during microsphere formation (20).
Particle size
In general, the size of microspheres ranged from 17 to 58 µm. Particle size increased
with an increase in polymer concentration and particle size decreased with a decrease in
polymer concentration. For instance, as the amount of polymer increased from 1:1 to 1:3,
the particle size increased by the same factor. This can be explained by the fact that at
higher polymer concentration, the viscosity of polymer solution increased, thereby pro-
ducing bigger droplets during emulsification, which were later hardened due to the
evaporation of dichloromethane.
SEM and sphericity
SEM photographs of M2 and M4 are shown in Fig. 3. Non-aggregated microspheres
with spherical shape were obtained for both formulations. Moreover, M4 showed a
smooth surface, indicating that CTZ might be well dispersed inside the carrier. The
sphericity factor was obtained in the range of 1.00 to 1.04, indicating that the prepared
formulations were spherical.
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Fig. 3. SEM pictures of microsphere formulation M2 at: a) 1500×, b) 2400× magnification, and M4 at:
c) 2500× and d) 8000× magnification.
Drug loading and encapsulation efficiency
Encapsulation efficiency ranged from 55 to 88 %. It was found that the encapsula-
tion efficiency and drug content increased with increasing amounts of polymers in the
microspheres. Formulations M3 and M6 showed a relatively higher encapsulation effi-
ciency, these formulations contained a high polymer concentration. It can be inferred
from the results that there was a proper distribution of CTZ in the microspheres. The de-
crease in drug content in the product was probably due to the loss of drug with the ex-
haust gas during the spray drying process. During the microencapsulation process, me-
chanical variables cause loss of the final product and hence process yield may not be 100 %.
Among all formulations, M1 containing 1000 mg of Eudragit RS 100 and M4 containing
1000 mg of Eudragit RL 100 showed maximum drug loading of 27.9 and 28.6 %, respec-
tively. The results obtained are given in Table I.
Mucoadhesive tablets prepared were evaluated and the results obtained are given
in Table II. Thickness, average mass, hardness and percentage friability of the prepared
tablets were found to be satisfactory (14).
All the formulations showed considerable swelling properties in acidic pH, which
was due to the presence of hydrophilic polymers in the formulations. Polymeric matri-
ces start to swell and build a gel layer around the tablet core when they come in contact
with the medium which governs drug release. HPMC took more time to swell and was
able to maintain the integrity of tablets. SCMC and Carbopol 934 are readily swellable
polymers and showed good mucoadhesion properties. During the initial hours, swelling
was the predominant factor compared to erosion. Percentage of swelling gradually de-
creased in all formulations after 10 hours, since the polymer eroded at a faster rate com-
pared to the initial slow erosion. Results are shown graphically in Fig. 5. Similar results
are reported in the literature (7).
In vitro drug release studies
The release profile of the drug from microspheres clearly indicates that the concen-
tration of polymers slows the release of CTZ from microspheres. At the end of 12 h, in vi-
tro drug release from formulations M1 to M6 was found to be 83.1 to 98.9 % in the vagi-
nal environment, as shown in Fig. 4. The total cumulative quantity of the drug released
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Fig. 4. Drug release profile of clotrimazole from microspheres (mean ± SD, n = 3).
at the end of the 12 h dissolution test was below 100 % for all dosage forms. This may be
in part due to the relatively slow erosion of the matrix under these test conditions, with
a resultant slow release of entrapped drug from the matrices undergoing testing. Among
various formulations, M4 was found to have a good release pattern and controlled re-
lease up to 12 h. Hence, M4 was selected as the optimized formulation and incorporated
in the prepared tablet.
Formulations made with a single polymer like HPMC showed a burst effect when
they came in contact with the fluid. To avoid such a burst effect, a combination of poly-
mers was used in different ratios. The selected polymers such as HPMC, SCMC, and
Carbopol 934 showed better mucoadhesive properties when they were used in higher
concentrations and thereby released the drug for a prolonged period of time. It was
found that the Mt6 formulation containing a combination of polymers HPMC and
369
N. Vishal Gupta et al.: Bioadhesive vaginal tablets containing spray dried microspheres loaded with clotrimazole for treatment of
vaginal Candidiasis, Acta Pharm. 63 (2013) 359–372
Fig. 5. Swelling of bioadhesive tablet formulations in citrate phosphate buffer pH 4.5 (mean ± SD,
n = 3).
Fig. 6. Drug release profile of tablet formulations and control tablet (mean ± SD, n = 3).
Carbopol showed better in vitro release of 95 % after 24 h as well as mucoadhesive pro-
perties. These results are in good agreement with the previous study (7). In vitro drug re-
lease was considerably retarded from the tablet compared to control tablets. From the
data, Mt6 was chosen as the optimized formulation and compared with the control tab-
let. Control tablet released a maximum of 98 % of CTZ up to 12 h. Bioadhesive tablets
provided controlled release of CTZ up to 24 h. Drug release was faster from the control
tablet in the initial period; about 65 % of the drug was released after 5 h and 98 % was
released by the 10th hour, whereas drug release from Mt6 was controlled up to 24 h;
about 72 % of the drug was released after 12 h (Fig. 6). A previous report showed con-
trolled release up to 6 h using chitosan-thioglycolic acid conjugate (8). In another work,
drug release retarding agents were not employed, which resulted in controlled release of
up to 6 h but the duration of bioadhesion was reported to be up to 50 h.
In vitro antifungal studies
An antifungal study with Sabouraud culture medium showed that the CTZ tablet
loaded with microspheres was able to control (inhibit) the growth of Candida albicans for
more than 12 h. The placebo tablet did not show any zone of inhibition. The Mt6 formu-
lation showed an average zone of inhibition of 18.6 ± 0.5 mm, which was higher com-
pared to the average zone of inhibition of pure metronidazole (13.4 ± 0.4 mm).
In vitro and in vivo bioadhesive strength
In vitro mucoadhesion testing of tablets was done by detachment force measure-
ments. Increased polymer concentration caused an increase in mucoadhesive strength.
The combination of HPMC with Carbopol formulation showed higher mucoadhesive
strength than the formulation with SCMC. The optimized bioadhesive formulation help-
ed the tablet stay in the vagina and thereby enhanced its retention (Table II).
The bioadhesive tablet Mt6 was administered intravaginally to a rabbit and showed
tablet bioadhesion and retention for 24 h (data not shown). It was evident that the tablet
showed swelling, remained intact, and adhered to the vaginal mucous membrane for
over 12 h. After 24 h, a gelous mass remaining on the spot of administration was seen.
The study was in accord with the in vitro studies and confirmed the bioadhesion and re-
tention of the tablet in the vagina.
CONCLUSIONS
The system of bioadhesive tablets containing CTZ loaded microspheres for bioadhe-
sive vaginal drug delivery has demonstrated their effectiveness for the intended action.
The in vitro bioadhesive strength and adhesion time studies have shown the ability of
these tablets to adhere to the vaginal mucosa for an extended period of time as well as to
improve drug availability. It can be concluded from the results of the present experimen-
tal work, that the formulation is easy to administer, simple and comfortable. Hence, clo-
trimazole could be formulated into this type of drug delivery system for controlled drug
release.
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